首頁 › 大腸直腸癌 › 加州 › San Francisco
San Francisco, CA 的 大腸直腸癌 臨床試驗
18 項針對 大腸直腸癌 的研究正在 San Francisco（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- UCSF at China Basin, San Francisco
- UCSF at Mount Zion, San Francisco
- UCSF at Parnassus, San Francisco
- 還有 1 項
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
招募中2/3 期
- Local Institution - 0317, San Francisco
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
招募中1/2 期
- University of California, San Francisco (UCSF), San Francisco
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
招募中3 期
- Clinical Study Site, San Francisco
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
招募中1 期
- UCSF, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
招募中
- University of California, San Francisco, San Francisco
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
招募中1 期
- UCSF, San Francisco
A Study of DM002 in Patients With Advanced Solid Tumors
招募中1/2 期
- University of California San Francisco Cancer Center, San Francisco
LYL273 for Patients With Relapsed or Refractory mCRC
招募中1/2 期
- University of California San Francisco Medical Center, San Francisco
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
招募中1 期
- University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco
A Study of MGC028 in Participants With Advanced Solid Tumors
招募中1 期
- UCSF - Helen Diller Family Cancer Center, San Francisco
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
招募中1/2 期
- University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
招募中觀察性研究
- Kaiser Permanente-San Francisco, San Francisco
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
招募中1/2 期
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
A Multicenter Cancer Biospecimen Collection Study
招募中觀察性研究
- Curebase, San Francisco
A Study of IBI363 in Subjects with Advanced Solid Malignancies
招募中2 期
- University of California, San Francisco (UCSF), San Francisco
其他城市的 大腸直腸癌 試驗
- Houston, TX102 項研究
- New York City, NY78 項研究
- Nashville, TN69 項研究
- Boston, MA63 項研究
- Los Angeles, CA59 項研究
- Arlington, VA52 項研究
- St. Louis, MO50 項研究
- San Antonio, TX46 項研究
- Philadelphia, PA44 項研究
- Grand Rapids, MI40 項研究
- Baldwin Park, CA37 項研究
- Chicago, IL34 項研究
San Francisco 的其他研究
- 前列腺癌45 項研究
- 乳癌43 項研究
- 非小細胞肺癌36 項研究
- 癌症（所有類型）35 項研究
- 心臟衰竭29 項研究
- 轉移性癌症28 項研究
- 肺癌22 項研究
- 黑色素瘤22 項研究
- 胰臟癌20 項研究
- 卵巢癌19 項研究
- 心血管疾病18 項研究
- 膠質母細胞瘤17 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。